Breath-taking News

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

Elizabeth Helene Louw

Author's affiliations

Elizabeth Helene Louw, Tygerberg Hospital

Full Text:

PDF (65KB)

Cite this article

African Journal of Thoracic and Critical Care Medicine 2021;27(1):32. DOI:10.7196/AJTCCM.2021.v27i1.140

Article History

Date submitted: 2021-03-09
Date published: 2021-03-09

Article Views

Abstract views: 164
Full text views: 201

Refbacks

  • There are currently no refbacks.



African Journal of Thoracic and Critical Care Medicine| Online ISSN: 2617-0205

This journal is protected by a Creative Commons Attribution - NonCommercial Works License (CC BY-NC 4.0) | Read our privacy policy.

Our Journals: South African Medical Journal | African Journal of Health Professions Education | South African Journal of Bioethics and Law | South African Journal of Child Health | Southern African Journal of Critical Care | African Journal of Thoracic and Critical Care MedicineSouth African Journal of Obstetrics and Gynaecology |